Medicare contract · plan years 2026 and 2027CMS landscape and crosswalk
Care Improvement Plus South Central Insurance Co. (H2292)
H2292Contract
A company of UnitedHealth Group, Inc., sold as UnitedHealthcare
2 plans in 2027 (2 in 2026) · 8,846 members in September 2026
Care Improvement Plus South Central Insurance Co. is the UnitedHealth Group, Inc. company that holds Medicare contract H2292, sold as UnitedHealthcare. In 2027 it offers 2 plans (2 in 2026); every one of its 2026 plans continues in 2027. 8,846 people were in its plans in September 2026.
What plans does H2292 offer for 2027?
| Plan | Type | Monthly premium | Out-of-pocket limit | Area | For 2027 |
|---|---|---|---|---|---|
| UHC Nursing Home Plan NY-F001H2292-001 | PPO I-SNP | $4.20 | $9,850 | 26 counties | renews in fewer counties |
| UHC Nursing Home Plan NY-F002H2292-002 | PPO I-SNP | $0 | $9,850 | 12 counties | renews |
Source: CMS Medicare Advantage and Part D landscape files for 2027 (Sept. 22, 2026, revised Sept. 30) and 2026 (Sept. 2, 2026 revision); CMS plan crosswalk from 2026 to 2027 (Oct. 1, 2026).
How did CMS rate it for 2026?
The overall rating is 4.5 of 5 (health plan 3.5 of 5, drug plan 5 of 5). Of its 26 rated measures, the lowest and the highest:
| Lowest-rated measures | Stars |
|---|---|
| Plan All-Cause Readmissions | 1 |
| Follow-up after Emergency Department Visit for People with Multiple High-Risk Chronic Conditions | 1 |
| Colorectal Cancer Screening | 2 |
| Controlling High Blood Pressure | 2 |
| Highest-rated measures | Stars |
|---|---|
| Statin Use in Persons with Diabetes (SUPD) | 5 |
| Medication Adherence for Cholesterol (Statins) | 5 |
| Medication Adherence for Diabetes Medications | 5 |
| Drug Plan Quality Improvement | 5 |
Source: CMS Part C and D Star Ratings data tables, 2026 (October 2025).
What else should you check?
- All UnitedHealthcare plansEvery contract of the brand
- Star ratings of every contractThe 2026 ratings, and 2027 when CMS publishes them
- Find a plan by its IDFrom the card or a letter